Glucose-6-Phosphate Dehydrogenase Antikörper (AA 351-450)

Produktnummer ABIN1387380

Produktdetails anti-Glucose-6-Phosphate Dehydrogenase Antikörper

Target: Glucose-6-Phosphate Dehydrogenase (G6PD)

Bindungsspezifität: AA 351-450

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Glucose-6-Phosphate Dehydrogenase Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Cow,Sheep,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Glucose 6 Phosphate Dehydrogenase

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu Glucose-6-Phosphate Dehydrogenase

Target: Glucose-6-Phosphate Dehydrogenase (G6PD)

Andere Bezeichnung: Glucose 6 Phosphate Dehydrogenase (G6PD Produkte)

Synonyme: G6PD1 antikoerper, g6pd antikoerper, G6pd antikoerper, G6pdx antikoerper, g6pdh antikoerper, g6pd2 antikoerper, fj78b06 antikoerper, wu:fj78b06 antikoerper, si:dkey-90a13.8 antikoerper, BA3433 antikoerper, CORTRD1 antikoerper, G6PDH antikoerper, GDH antikoerper, G28A antikoerper, G6PD antikoerper, Gpdx antikoerper, glucose-6-phosphate dehydrogenase antikoerper, glucose-6-phosphate 1-dehydrogenase antikoerper, glucose-6-phosphate 1-dehydrogenase (G6PD) antikoerper, glucose-6-P dehydrogenase antikoerper, glucose-6-phosphate dehydrogenase L homeolog antikoerper, glucose-6-phosphate 1-dehydrogenase Zwf antikoerper, hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase antikoerper, glucose-6-phosphate dehydrogenase X-linked antikoerper, G6PD antikoerper, g6pd antikoerper, g6pD antikoerper, zwf antikoerper, LOC100120232 antikoerper, LACBIDRAFT_188936 antikoerper, G6pd antikoerper, g6pd.L antikoerper, CNG03280 antikoerper, Tb10.70.5200 antikoerper, H6PD antikoerper, G6pdx antikoerper, H6pd antikoerper

Hintergrund:

Synonyms: G6PD, G6PD_HUMAN, G6PD1, G6pdx, Glucose 6 phosphate 1 dehydrogenase, Glucose-6-phosphate 1-dehydrogenase, MET19, POS10, Zwf1p.

Background: Defects in G6PD are the cause of chronic non-spherocytic hemolytic anemia (CNSHA) . Deficiency of G6PD is associated with hemolytic anemia in two different situations. First, in areas in which malaria has been endemic, G6PD-deficiency alleles have reached high frequencies (1 % to 50 %) and deficient individuals, though essentially asymptomatic in the steady state, have a high risk of acute hemolytic attacks. Secondly, sporadic cases of G6PD deficiency occur at a very low frequencies, and they usually present a more severe phenotype. Several types of CNSHA are recognized. Class-I variants are associated with severe NSHA, class-II have an activity <10 % of normal, class-III have an activity of 10 % to 60 % of normal, class-IV have near normal activity.

Pathways: Regulation of Systemic Arterial Blood Pressure by Hormones